Conjunctivitis News and Research

RSS
Conjunctivitis is an eye infection that may cause redness and discharge from the eye, sometimes with pain or itching. It can be caused by bacteria or viruses.
Urgent care and retail health clinics can reduce treatment costs for allergy sufferers

Urgent care and retail health clinics can reduce treatment costs for allergy sufferers

Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV

Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV

Inspire Pharmaceuticals reports net loss of $14.8M for first-quarter 2010

Inspire Pharmaceuticals reports net loss of $14.8M for first-quarter 2010

NovaBay to present data on Aganocide compounds at ARVO annual meeting

NovaBay to present data on Aganocide compounds at ARVO annual meeting

ISTA Pharmaceuticals first-quarter net revenues up 39%

ISTA Pharmaceuticals first-quarter net revenues up 39%

Milwaukee child care directors unnecessarily send mild illness children home: Study

Milwaukee child care directors unnecessarily send mild illness children home: Study

Japanese ministry approves DIQUAS Ophthalmic Solution 3% for dry eye treatment

Japanese ministry approves DIQUAS Ophthalmic Solution 3% for dry eye treatment

Persisting red, itchy, watery eyes in children may be signs of serious conditions

Persisting red, itchy, watery eyes in children may be signs of serious conditions

Common remedies can make ocular symptoms worse: MOA

Common remedies can make ocular symptoms worse: MOA

NovaBay Pharmaceuticals reports net income of $2.7M for 2009 against year-ago loss

NovaBay Pharmaceuticals reports net income of $2.7M for 2009 against year-ago loss

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

Perrigo introduces generic Zaditor

Perrigo introduces generic Zaditor

Inspire Pharmaceuticals reports results of two AZASITE Phase 2 clinical trials for blepharitis

Inspire Pharmaceuticals reports results of two AZASITE Phase 2 clinical trials for blepharitis

QLT announces results from Phase II clinical trials and device study for PPDS

QLT announces results from Phase II clinical trials and device study for PPDS

Inspire Pharmaceuticals reports net loss of $2.6 million for 2009 fourth quarter

Inspire Pharmaceuticals reports net loss of $2.6 million for 2009 fourth quarter

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

NanoViricides files quarterly report with Securities and Exchange Commission

NanoViricides files quarterly report with Securities and Exchange Commission

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

Antibiotics program of Giant Eagle results in more than $3M in free prescriptions for customers

Antibiotics program of Giant Eagle results in more than $3M in free prescriptions for customers

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved